Literature DB >> 24567035

Toll‑like receptor 2 promotes bacterial clearance during the initial stage of pulmonary infection with Acinetobacter baumannii.

Chang-Hwan Kim1, Dong-Jae Kim2, Sang-Jin Lee2, Yu-Jin Jeong2, Min-Jung Kang2, Jun-Young Lee2, Jin-A Choi2, Sun-Jung Kwon3, Jae-Hak Park1, Jong-Hwan Park2.   

Abstract

Toll‑like receptor 2 (TLR2) has been identified as a sensor for bacterial lipoprotein. To determine the role of TLR2 in host defense against Acinetobacter baumannii infection, wild‑type (WT) and TLR2‑deficient mice were infected intranasally with A. baumannii. Body weight, cytokine and chemokine levels in bronchoalveolar (BAL) fluid and lung histopathology were examined. Body weight changes in TLR2‑deficient mice were comparable to those of WT mice throughout the experimental period. However, TLR2‑deficient mice exhibited an increased bacterial load in the lungs and increased levels of interleukin‑6 and chemokine (C‑X‑C motif) ligand 2 in BAL fluids compared with WT mice 1 day after infection. Histopathological features of lung tissue in WT and TLR2‑deficient mice were comparable between WT and TLR2‑deficient mice. Results of the present study demonstrate that TLR2 may have a minimal role in the host defense against A. baumannii at the early stages of infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24567035     DOI: 10.3892/mmr.2014.1966

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

1.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

2.  NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice.

Authors:  Min-Jung Kang; Sung-Gang Jo; Dong-Jae Kim; Jong-Hwan Park
Journal:  Immunology       Date:  2017-01-30       Impact factor: 7.397

Review 3.  Innate Immune Responses to Acinetobacter baumannii in the Airway.

Authors:  Sílvia Pires; Dane Parker
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

4.  Acinetobacter baumannii Outer Membrane Protein A Induces Pulmonary Epithelial Barrier Dysfunction and Bacterial Translocation Through The TLR2/IQGAP1 Axis.

Authors:  Wang Zhang; Hua Zhou; Yan Jiang; Jintao He; Yue Yao; Jianfeng Wang; Xiaochen Liu; Sebastian Leptihn; Xiaoting Hua; Yunsong Yu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  Divergent functions of Toll-like receptors during bacterial lung infections.

Authors:  Pankaj Baral; Sanjay Batra; Rachel L Zemans; Gregory P Downey; Samithamby Jeyaseelan
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

6.  Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs.

Authors:  Sandeep D Kale; Neha Dikshit; Pankaj Kumar; Vanniarajan Balamuralidhar; Hanif Javanmard Khameneh; Najib Bin Abdul Malik; Tse Hsien Koh; Gladys Gek Yen Tan; Thuan Tong Tan; Alessandra Mortellaro; Bindu Sukumaran
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

7.  Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence.

Authors:  Susanna Esposito; Manuel E Soto-Martinez; Wojciech Feleszko; Marcus H Jones; Kun-Ling Shen; Urs B Schaad
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-06

Review 8.  Host Innate Immune Responses to Acinetobacter baumannii Infection.

Authors:  Wangxue Chen
Journal:  Front Cell Infect Microbiol       Date:  2020-09-14       Impact factor: 5.293

9.  Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.

Authors:  Susanna Esposito; Micaela Garziano; Veronica Rainone; Daria Trabattoni; Mara Biasin; Laura Senatore; Paola Marchisio; Marta Rossi; Nicola Principi; Mario Clerici
Journal:  J Transl Med       Date:  2015-09-03       Impact factor: 5.531

Review 10.  The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.

Authors:  María Guadalupe García-Patiño; Rodolfo García-Contreras; Paula Licona-Limón
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.